Fyarro

Coverage eligibility for Sirolimus protein-bound particles (Fyarro) will be considered when the following criteria are met:

Fyarro may be considered medically necessary in adult for Malignant perivascular epithelioid cell tumor, locally advanced unresectable or metastatic